Drug factory · FDA FEI 3002807897
Novetide Ltd.
1 Haplada, Industrial Zone, Netanya, Israel
No problems found at FDA's last inspection, Nov 14, 2019.
No Action Indicated: inspectors found no objectionable conditions.
3 drug inspections on record since 2013: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Bivalirudin | Makes the active ingredient | Sandoz Inc. | 0781-3158 |
| Octreotide | Makes the active ingredient | Amryt Pharmaceuticals Designated Activity Company, Chiesi USA, Inc. | 69880-120, 10122-550 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 14, 2019 | No problems found | Drug Quality Assurance | — |
| May 28, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 7, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.